|
Biosignatures are developing next generation molecular diagnostic
tests to arm clinicians and healthcare providers with exceptionally
accurate tools for the rapid diagnosis of disease. This means treatment
plans for patients affected by a disease can be administered with
greater confidence - drastically improving patient care.
Urology, Freeman Hospital, Newcastle Study
Urology, Sunderland Royal Hospital, Sunderland Study
Participant lifestyle questionnaire
|